These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 15479819)
1. The C-mer gene is induced by Epstein-Barr virus immediate-early protein BRLF1. Li Y; Mahajan NP; Webster-Cyriaque J; Bhende P; Hong GK; Earp HS; Kenney S J Virol; 2004 Nov; 78(21):11778-85. PubMed ID: 15479819 [TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus immediate-early protein BRLF1 induces the lytic form of viral replication through a mechanism involving phosphatidylinositol-3 kinase activation. Darr CD; Mauser A; Kenney S J Virol; 2001 Jul; 75(13):6135-42. PubMed ID: 11390615 [TBL] [Abstract][Full Text] [Related]
3. Fatty acid synthase expression is induced by the Epstein-Barr virus immediate-early protein BRLF1 and is required for lytic viral gene expression. Li Y; Webster-Cyriaque J; Tomlinson CC; Yohe M; Kenney S J Virol; 2004 Apr; 78(8):4197-206. PubMed ID: 15047835 [TBL] [Abstract][Full Text] [Related]
4. The BRRF1 early gene of Epstein-Barr virus encodes a transcription factor that enhances induction of lytic infection by BRLF1. Hong GK; Delecluse HJ; Gruffat H; Morrison TE; Feng WH; Sergeant A; Kenney SC J Virol; 2004 May; 78(10):4983-92. PubMed ID: 15113878 [TBL] [Abstract][Full Text] [Related]
6. Induction of lytic Epstein-Barr virus (EBV) infection in EBV-associated malignancies using adenovirus vectors in vitro and in vivo. Westphal EM; Mauser A; Swenson J; Davis MG; Talarico CL; Kenney SC Cancer Res; 1999 Apr; 59(7):1485-91. PubMed ID: 10197618 [TBL] [Abstract][Full Text] [Related]
7. Rescue of the Epstein-Barr virus BZLF1 mutant, Z(S186A), early gene activation defect by the BRLF1 gene product. Adamson AL; Kenney SC Virology; 1998 Nov; 251(1):187-97. PubMed ID: 9813214 [TBL] [Abstract][Full Text] [Related]
8. De novo protein synthesis is required for lytic cycle reactivation of Epstein-Barr virus, but not Kaposi's sarcoma-associated herpesvirus, in response to histone deacetylase inhibitors and protein kinase C agonists. Ye J; Gradoville L; Daigle D; Miller G J Virol; 2007 Sep; 81(17):9279-91. PubMed ID: 17596302 [TBL] [Abstract][Full Text] [Related]
9. Lytic cycle switches of oncogenic human gammaherpesviruses. Miller G; El-Guindy A; Countryman J; Ye J; Gradoville L Adv Cancer Res; 2007; 97():81-109. PubMed ID: 17419942 [TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 alter mitochondrial morphology during lytic replication. LaJeunesse DR; Brooks K; Adamson AL Biochem Biophys Res Commun; 2005 Jul; 333(2):438-42. PubMed ID: 15950179 [TBL] [Abstract][Full Text] [Related]
11. Multiple roles of Epstein-Barr virus SM protein in lytic replication. Han Z; Marendy E; Wang YD; Yuan J; Sample JT; Swaminathan S J Virol; 2007 Apr; 81(8):4058-69. PubMed ID: 17287267 [TBL] [Abstract][Full Text] [Related]
12. Epstein-Barr virus (EBV) EB1/Zta protein provided in trans and competent for the activation of productive cycle genes does not activate the BZLF1 gene in the EBV genome. Le Roux F; Sergeant A; Corbo L J Gen Virol; 1996 Mar; 77 ( Pt 3)():501-9. PubMed ID: 8601788 [TBL] [Abstract][Full Text] [Related]
13. Roles of lytic viral infection and IL-6 in early versus late passage lymphoblastoid cell lines and EBV-associated lymphoproliferative disease. Jones RJ; Seaman WT; Feng WH; Barlow E; Dickerson S; Delecluse HJ; Kenney SC Int J Cancer; 2007 Sep; 121(6):1274-81. PubMed ID: 17520680 [TBL] [Abstract][Full Text] [Related]
15. In situ RT-PCR detection of Epstein-Barr virus immediate-early transcripts in CD4+ and CD8+ T lymphocytes. Guan M; Romano G; Henderson EE Anticancer Res; 1998; 18(5A):3171-80. PubMed ID: 9858880 [TBL] [Abstract][Full Text] [Related]
16. RhoA/phosphatidylinositol 3-kinase/protein kinase B/mitogen-activated protein kinase signaling after growth arrest-specific protein 6/mer receptor tyrosine kinase engagement promotes epithelial cell growth and wound repair via upregulation of hepatocyte growth factor in macrophages. Lee YJ; Park HJ; Woo SY; Park EM; Kang JL J Pharmacol Exp Ther; 2014 Sep; 350(3):563-77. PubMed ID: 24939420 [TBL] [Abstract][Full Text] [Related]
17. The Epstein-Barr virus BRLF1 gene product transactivates the murine and human c-myc promoters. Gutsch DE; Marcu KB; Kenney SC Cell Mol Biol (Noisy-le-grand); 1994 Sep; 40(6):747-60. PubMed ID: 7812182 [TBL] [Abstract][Full Text] [Related]
18. Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas. Feng WH; Cohen JI; Fischer S; Li L; Sneller M; Goldbach-Mansky R; Raab-Traub N; Delecluse HJ; Kenney SC J Natl Cancer Inst; 2004 Nov; 96(22):1691-702. PubMed ID: 15547182 [TBL] [Abstract][Full Text] [Related]
19. hTERT inhibition triggers Epstein-Barr virus lytic cycle and apoptosis in immortalized and transformed B cells: a basis for new therapies. Giunco S; Dolcetti R; Keppel S; Celeghin A; Indraccolo S; Dal Col J; Mastorci K; De Rossi A Clin Cancer Res; 2013 Apr; 19(8):2036-47. PubMed ID: 23444223 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of nasopharyngeal carcinoma growth by RTA-expressing baculovirus vectors containing oriP. Wang L; Shan L; Lo KW; Yin J; Zhang Y; Sun R; Zhong J J Gene Med; 2008 Oct; 10(10):1124-33. PubMed ID: 18642396 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]